PubMed ·
Cardiovascular protection beyond glucose lowering: GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonism in contemporary cardiology.
- Published
- Source
- PubMed
- Original
- Read it at PubMed
- Topics
In brief
GLP-1s: More Than Just Sugar Control
This review synthesizes recent studies, highlighting how GLP-1RAs and the dual GIP/GLP-1 agonist tirzepatide can reduce major adverse cardiovascular events (MACE) and improve outcomes in patients with obesity and heart failure.
What they found: The review reveals that GLP-1RAs significantly reduce major adverse cardiovascular events (MACE) by approximately 20% in type 2 diabetes patients. Notably, tirzepatide shows a 30% reduction in worsening heart failure events. Additionally, semaglutide provides substantial kidney protection, with a 40% reduction in complications.
AI-written summary, not medical advice. Check anything you rely on against the original paper.
From the abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide have expanded from glucose-lowering therapy into cardiovascular medicine.
The opening of the authors’ abstract. The rest is with PubMed.
Read it on ReadSearch
Each opens after you create an account, and brings you back to this paper.
More in Cardiology
Cardiac changes in children with post-streptococcal glomerulonephritis: a prospective observational study.
The Intradialytic Changes in Cardiac Troponin I-A Systematic Review.
The Electrocardiogram-Based Phase Adjustment Task (PAT-ECG): An Open-Access Laboratory Test of Cardiac Interoceptive Accuracy.
Modelling eCPR eligibility after out-of-hospital cardiac arrest: a 10-year retrospective temporospatial analysis from a mixed urban-rural region in Germany.
Advances in the Mechanisms Underlying Brain Injury after Resuscitation from Cardiac Arrest.
Get the few papers worth your time in Cardiology every morning.
ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.